knowledge -WSS

knowledge

author：focus 2025-10-02 19:38:28 - browse：75

Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT — Molly Ferguson for STAT

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Problems with a popular proposal to regulate AI in health care

WSS

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Bernie brings in new pharma CEOs to talk drug prices

Free medical tuition alone isn't enough to close gaps in primary care

ALS treatment from Biogen, Ionis fails in study

The United States must get value

Top private equity targets in 2023: cardiology, clinical trials, lasers

hotspot

knowledge

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Trump demands the U.S. pay no more for drugs than other countries … again

CVS is willing to dump 10% of its Medicare Advantage members

Wildfire smoke exposes gaps in outdoor worker protections

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Tori Bowie and the unacceptable rates of Black maternal death

Oak Street deal isn't the answer to health care's woes

How one medical school became remarkably diverse

Surgery pushed Ben Carson to fame

explore

Why Novartis is going to walk from its acquisition of MorphoSys

The White House hikes tariffs on plastic syringes made in China

340B reform proposal comes out of Senate working group

What a koala virus tells us about the human genome

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Free medical tuition alone isn't enough to close gaps in primary care

hotspot

knowledge

hotspot

focus